Sign up for our newsletter
Join our scientific community to stay up to date with Element news, insights, and product updates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
January 4, 2023
Press
SAN DIEGO, CA (January 4, 2023) – Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — announced that Element CEO and Co-Founder Molly He will speak at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time) at the Westin St. Francis hotel in San Francisco.
About Element Biosciences, Inc.
Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating the fundamental elements of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, in turn accelerating scientific discoveries and broadening the use of genomic medicine. To learn more about Element, visit www.elementbiosciences.com.
Media Contact:
Kristi Heim
Element Biosciences
Kristi.Heim@elembio.com